➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Medtronic
AstraZeneca
Baxter
Colorcon

Last Updated: September 28, 2021

DrugPatentWatch Database Preview

Details for Patent: 9,268,909


Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,268,909
Title:Apparatus, system, and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device
Abstract: Provided is an apparatus, system, and method for stabilizing battery voltage of a battery device while optimizing power delivered to a receiver during communication of a broadcast packet. A logic circuit is configured to receive a broadcast packet having a predetermined number of bits for communication by a controller to a receiver located remotely from the controller, determine a number of cycles in which a sampled battery voltage is either greater than or less than or equal to a nominal battery voltage over a first subset of the predetermined number of bits of the broadcast packet and performs either a tune-up or a tune-down procedure based on the number of cycles counted in which the sampled battery voltage is not equal to the nominal battery voltage for more than one half of a total number of cycles counted.
Inventor(s): Jani; Nilay (San Jose, CA), Webb; Douglas (Los Altos, CA), Withrington; Jonathan (San Francisco, CA), Berkman; Jeffrey (Saratoga, CA), Li; Haifeng (Sunnyvale, CA)
Assignee: Proteus Digital Health, Inc. (Redwood City, CA)
Application Number:14/435,240
Patent Claim Types:
see list of patent claims
Use; Device;

Drugs Protected by US Patent 9,268,909

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-001 Nov 13, 2017 RX Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial Y METHOD OF USING A LOGIC CIRCUIT TO STABILIZE BATTERY VOLTAGE SUPPLIED TO A SENSOR EMBEDDED WITH A TABLET AND THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER ⤷  Free Forever Trial
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-002 Nov 13, 2017 RX Yes Yes ⤷  Free Forever Trial ⤷  Free Forever Trial Y METHOD OF USING A LOGIC CIRCUIT TO STABILIZE BATTERY VOLTAGE SUPPLIED TO A SENSOR EMBEDDED WITH A TABLET AND THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER ⤷  Free Forever Trial
Otsuka ABILIFY MYCITE KIT aripiprazole TABLET;ORAL 207202-003 Nov 13, 2017 RX Yes No ⤷  Free Forever Trial ⤷  Free Forever Trial Y METHOD OF USING A LOGIC CIRCUIT TO STABILIZE BATTERY VOLTAGE SUPPLIED TO A SENSOR EMBEDDED WITH A TABLET AND THAT COMMUNICATES INFORMATION VIA A SIGNAL THROUGH THE BODY OF A PATIENT TO A RECEIVER ⤷  Free Forever Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,268,909

PCT Information
PCT FiledOctober 15, 2013PCT Application Number:PCT/US2013/065041
PCT Publication Date:April 24, 2014PCT Publication Number: WO2014/062674

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Johnson and Johnson
Baxter
AstraZeneca
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.